Newcomer named Slingshot AI's Daniel Cahn among 18 leaders transforming healthcare, invited to speak at its Deus Ex Medicina AI health summit alongside founders of OpenEvidence, Abridge, Oura, Noom, and Hippocratic AI, and investors including Vinod Khosla.
In its preview of Deus Ex Medicina, an AI health and longevity summit in San Francisco, Newcomer named Slingshot AI co-founder and CEO Daniel Cahn among 18 leaders "transforming the industry through startups, investing, and policy." The roster places Slingshot in notable company, including the founders of OpenEvidence, Mammoth Biosciences, Formation Bio, Abridge, Maven, Hippocratic AI, Benchling, and Akido Labs, alongside Oura CEO Tom Hale, Noom founder Saeju Jeong, investor Vinod Khosla of Khosla Ventures, and Harvard Medical School professor Dr. Robert Green. Newcomer notes the speakers' companies have collectively raised more than $5 billion and that the event draws 175-plus health leaders. For Slingshot, the inclusion is a signal of standing: Ash and its founder are positioned among the most closely watched names building the future of AI in healthcare.
